share_log

HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20

HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20

HC Wainwright & Co.維持對AngioDynamics的買入,將目標價上調至20美元
Benzinga ·  2023/10/05 07:12

HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises the price target from $19 to $20.

HC Wainwright&Co.分析師陳毅維持AngioDynamic(納斯達克:ANGO)的買入,並將目標價從19美元上調至20美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論